Unit 1 General Concept Review Flashcards
Nucleus
Contains DNA and RNA arranged into chromatids.
Present in all cells except RBCs and platelets
Main overseer of cytoplasmic events
Cytoplasm
Cellular contents between cellular membrane and nucleus
Contains organelles and cytosol
Mitochondria
Organelle involved primarily in the (aerobic) production of ATP
Ribosomes
Small granules of rRNA
Either free or attached to RER
Protein synthesis (free => for internal use; RER => for export. Ish)
Cytosol
Fluid portion of cytoplasm
AKA intracellular fluid (ICF)
H2O, dissolved solutes, suspended particles
Hyaloplasm + microtubules and microfilaments
Smooth Endoplasmic Reticulum
Extends from RER
In liver, catabolism of drugs, hormones, carcinogens
Synthesis of steroids and fatty acids
In liver, kidneys and intestines, releases glucose into bloodstream
In muscles release Ca+
Rough Endoplasmic Reticulum
Protein production
Golgi Apparatus
Create secretory granules and lysosomes
Modify and package cellular products
Lysosomes
Membrane-bound digestive cytoplasmic organelles
Rich in lytic enzymes
Created by golgi apparatus
Hyaloplasm
Ground substance of cytoplasm;
Fluid portion of cytosl
Cytoskeleton
Composed of microfilaments (actin and myosin), microtubles, and intermediate filaments
Maintains cell shape; enables cell to adapt to external mechanical pressure.
Plasma membrane
Outer surface of cell.
Selectively permeable
Phosolipid bilayer
Hydrophobic inside, hydrophilic outside
Reversible cellular damage
Within range of homeostasis Cellular swelling and temporary loss of function: - reduced energy production - decreased protein synthesis - increased autophagy Membrane intact.
Irreversible Cell Damage
Overwhelming insult, toxins, anoxia –> nuclear changes and loss of membrane integrity
Atrophy
Decrease in the size of cells –> reduced tissue mass
Possible causes include age, poor nutrition, immobility
Hypertrophy
Increase in the size of individual cells –> increased tissue mass
Dysplasia
Inconsistent cell size and shape within a tissue.
Large nuclei, increased mitotic rate.
May indicate precancerous state
Hyperplasia
Increased number of cells –> increased tissue mass
Metaplasia
One mature cell type replaced by a different mature cell type
Apoptosis
Regulated, programmed cell death
Result of a series of molecular signals within cell
Cancer often involves impaired apoptosis
Autolysis
Death of cells and tissues in a dead organism
Necrosis
Exogenously induced cell death
Forms of necrosis
- coagulative
- liquefactive
- caseous
- enzymatic fat
Coagulative necrosis
Most common form of necrosis, most often caused by anoxia, most often in solid internal organs
Rapid inactivation of cytoplasmic hydrolytic enzymes –> prevents lysis of tissues
Tissues retain form and consistency
Liquefactive necrosis
Characterized by tissue dissolution.
Leukocytes invade necrotic tissue, release lytic enzymes, which transform solid tissue into liquid pus
Occurs most often in the brain
Secondary liquefaction
Tissue that have undergone coagulative necrosis may attract leukocytes and undergo liquefaction later on.
Caseous necrosis
Typically found in TB, as well as with some fungal infections
Coagulative necrosis with limited liquefaction
Enzymatic fat necrosis
Special form of liquefactive necrosis caused by action of LIPOlytic enzymes
Limited to fat tissue, usually around the pancreas. Usually digestive enzymes from damaged pancreas invade surrounding fatty tissue
Appears like liquified fat with whitish specks of calcium soap
Pancreatic enzymes degrade fat into ________. _______ react with _____ to create _______.
Glycerol and free fatty acids
Free fatty acids
Ca+
calcium soaps
Wet Gangrene
Bacterial infection of coagulated tissue, leading to secondary liquifaction
Dry Gangrene
Necrotic tissue dries out and becomes black and mummified.
Most often extremities, related to peripheral vascular disease
TB is associated with what sort of necrosis
caseous
Brains tend to undergo what sort of necrosis
liquefactive
Solid organs tend to undergo what sort of necrosis
coagulative
Fat surrounding the pancreas is prone to what sort of necrosis
enzymatic fat
Inflammation
The body’s nonspecific response to tissue injury
Cardinal signs of inflammation
Redness Swelling Heat Pain Loss of function
Pathogenesis of inflammation involves what four steps?
- changes in circulation of blood
- changes in vessel wall permeability
- release of soluble mediators of inflammation
- cellular actions
Inflammation: changes in circulation
First response to injury
- Vasoconstriction followed by vasodilation –> hyperemia
- blood flow slows –>congestion –> erythrocytes form rouleaux –> further impeding circulation
- WBC’s attach to endothelium (pavementing)
Inflammation: changes in vascular permeability
Second step
- increased pressure inside blood vessels and soluble mediators of inflammation cause endothelial cells to contract –> leaky endothelium
Difference between cell derived and plasma derived soluble mediators of inflammation
Plasma-derived must be activated
Cell-derived either prefab and stored in platelets and leukocytes, or created de novo
Histamine
Preformed SMI
Released by platelets and mast cells
=> immediate transient reaction
Increases endothelial leakiness
Bradykinin
Cell derived SMI, created de novo so takes longer to take effect.
Formed in plasma by activation of Coagulation Factory XII
Increases endothelial leakiness and incites pain.
Complement System
Cascade of protein activation following three paths (classical, alternative, lectin), all leading to formation of the Membrane Attack Complex (MAC)
Also causes histamine release, vasodilation, and promotes chemotaxis
Arachidonic Acid Derivatives
Cell membrane derived amino acids metabolized through two pathways:
- lipoxygenase
- cyclo-oxygenase
Lipoxygenase pathway
One of the Arachidonic Acid pathways
Creates:
1. leukotrienes (promote chemotaxis, increase vascular permeability)
2. lipoxins (inhibit chemotaxis)
Cyclo-oxygenase pathway
One of the arachidonic acid pathways
Produces
1. prostaglandins (vasodilation, vascular permeability, mediation of pain and fever)
2. thromboxane (platelet aggregation, thrombosis, vasoconstriction)
Soluble Mediators of Inflammation (SMIs)
Histamine
Bradykinin
Complement System
Arachidonic Acid Derivatives (Lipoxygenase and Cyclo-oxygenase pathways)
Cellular events associated with inflammation
Emigration of leukocytes
Phagocytosis
Chemotaxis
Leukocytes involved in inflammation
Polymorphonuclear neutrophils
Eosinophils
Basophils
Macrophages
Chemotaxis
Active movement of WBCs in respond to the release of chemical mediators
WBCs move up concentration gradient